SCHEMBL20118491

SCHEMBL20118491

Cc1ccc(/C(F)=C(\F)c2ccc(C)cc2)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.52
CES2 O00748 3/20 0.52
CES1 P23141 3/20 0.52
LMNA P02545 2/20 0.52
ACHE P22303 3/20 0.50
TDP1 Q9NUW8 3/20 0.50
SMN1; SMN2 Q16637 2/20 0.50
PKM P14618 2/20 0.46
HTT P42858 2/20 0.46
ATM Q13315 2/20 0.46
NPSR1 Q6W5P4 2/20 0.46
HPGD P15428 1/20 0.46
NLRP1 Q9C000 1/20 0.46
GAA P10253 1/20 0.46
MEN1 O00255 1/20 0.46
NTSR1 P30989 1/20 0.46
KMT2A Q03164 1/20 0.46
SRD5A2 P31213 1/20 0.44
HDAC1 Q13547 1/20 0.44
HDAC6 Q9UBN7 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20118718 0.89 ACHE (0.65) ALDH1A1CES2CES1LMNAACHE
SCHEMBL5329980 0.88 ALDH1A1 (0.48) ALDH1A1CES2CES1LMNAACHE
SCHEMBL20118501 0.86 ALDH1A1 (0.46) ALDH1A1CES2CES1LMNAACHE
SCHEMBL22745485 0.86 ALDH1A1 (0.46) ALDH1A1CES2CES1LMNAACHE
SCHEMBL20118719 0.82 CYP2A6 (0.54) ALDH1A1CES2CES1LMNATDP1
SCHEMBL17288381 0.81 ALDH1A1 (0.52) ALDH1A1CES2CES1LMNAACHE
SCHEMBL19309826 0.80 AKR1C3 (0.43) ALDH1A1CES2CES1LMNAACHE
SCHEMBL3126262 0.77 ALDH1A1 (0.48) ALDH1A1CES2CES1LMNAACHE
SCHEMBL8340738 0.77 ALDH1A1 (0.62) ALDH1A1CES2CES1LMNATDP1
SCHEMBL10686521 0.77 ALDH1A1 (0.43) ALDH1A1CES2CES1LMNATDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11667840-B2 Liquid-crystalline medium MERCK PATENT GMBH (DE) 2023-06-06 US disclosed
US-11667840-B2 Liquid-crystalline medium MERCK PATENT GMBH (DE) 2023-06-06 US disclosed
EP-3529331-B1 LIQUID-CRYSTALLINE MEDIUM MERCK PATENT GMBH (DE) 2020-10-07 EP disclosed
US-20190330530-A1 LIQUID-CRYSTALLINE MEDIUM MERCK PATENT GMBH (DE) 2019-10-31 US disclosed
WO-2018077765-A1 LIQUID-CRYSTALLINE MEDIUM MERCK PATENT GMBH (DE) 2018-05-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11667840-B2 Liquid-crystalline medium FES, BLM, CXCL12 ALDH1A1 3893/4885CES2 3736/4885CES1 4110/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.